4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Penn, A; Snyder, CA | 1 |
| Andrews, R; Barnhill, M; Elgayyar, M; Schuller, HM; Tithof, PK | 1 |
2 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Arteriosclerosis
| Article | Year |
|---|---|
1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development.
Topics: Air Pollutants; Animals; Arteriosclerosis; Butadienes; Chickens; Double-Blind Method; Humans; Male; Nitrosamines; Tobacco Smoke Pollution | 1996 |
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis of endothelial cells.
Topics: Animals; Aorta; Apoptosis; Arachidonic Acid; Arteriosclerosis; Carcinogens; Endothelium, Vascular; In Situ Nick-End Labeling; Nicotine; Nitrosamines; Receptors, Adrenergic, beta; Smoking; Swine; Tritium | 2001 |